ACADIA Pharmaceuticals Revenue 2006-2018 | ACAD

Current and historical revenue for ACADIA Pharmaceuticals (ACAD) from 2006 to 2018. Revenue can be defined as the sum of all revenue fields included for a company's operating activities. ACADIA Pharmaceuticals revenue for the twelve months ending June 30, 2018 was $0.185B. ACADIA Pharmaceuticals revenue for the three months ending June 30, 2018 was $0.057B, representing a 87.25% increase from the same quarter last year.
ACADIA Pharmaceuticals Annual Revenue
(Millions of US $)
2017 $125
2016 $17
2015 $0
2014 $0
2013 $1
2012 $5
2011 $2
2010 $42
2009 $6
2008 $2
2007 $8
2006 $8
2005 $11
ACADIA Pharmaceuticals Quarterly Revenue
(Millions of US $)
Q2 2018 $57
Q1 2018 $49
Q4 2017 $44
Q3 2017 $36
Q2 2017 $30
Q1 2017 $15
Q4 2016 $12
Q3 2016 $5
Q2 2016 $0
Q1 2016 $0
Q4 2015 $0
Q3 2015 $0
Q2 2015 $0
Q1 2015 $0
Q4 2014 $0
Q3 2014 $0
Q2 2014 $0
Q1 2014 $0
Q4 2013 $0
Q3 2013 $0
Q2 2013 $0
Q1 2013 $0
Q4 2012 $0
Q3 2012 $3
Q2 2012 $1
Q1 2012 $0
Q4 2011 $1
Q3 2011 $1
Q2 2011 $0
Q1 2011 $0
Q4 2010 $35
Q3 2010 $2
Q2 2010 $2
Q1 2010 $2
Q4 2009 $2
Q3 2009 $2
Q2 2009 $2
Q1 2009 $0
Q4 2008 $0
Q3 2008 $0
Q2 2008 $0
Q1 2008 $1
Q4 2007 $2
Q3 2007 $2
Q2 2007 $2
Q1 2007 $2
Q4 2006 $2
Q3 2006 $2
Q2 2006 $2
Q1 2006 $3
Q4 2005 $2
Q3 2005 $4
Q2 2005 $3
Q1 2005 $2
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.724B $0.125B
Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson's disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $126.386B 14.51
Gilead Sciences (GILD) United States $97.018B 10.77
Biogen (BIIB) United States $68.636B 14.55
Celgene (CELG) United States $62.789B 12.54
Illumina (ILMN) United States $48.190B 60.37
Vertex Pharmaceuticals (VRTX) United States $44.212B 100.58
Regeneron Pharmaceuticals (REGN) United States $39.102B 21.99
Alexion Pharmaceuticals (ALXN) United States $25.700B 19.32
BioMarin Pharmaceutical (BMRN) United States $18.080B 0.00
Incyte (INCY) United States $14.215B 477.64
Seattle Genetics (SGEN) United States $11.735B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.371B 60.17
Alnylam Pharmaceuticals (ALNY) United States $9.183B 0.00
BeiGene (BGNE) Cayman Islands $8.478B 0.00
QIAGEN (QGEN) Netherlands $8.461B 27.66
Bluebird Bio (BLUE) United States $8.357B 0.00
Sarepta Therapeutics (SRPT) United States $8.353B 0.00
Alkermes (ALKS) Ireland $6.797B 0.00
Bio-Techne Corp (TECH) United States $6.763B 45.45
Exact Sciences (EXAS) United States $5.928B 0.00
Exelixis (EXEL) United States $5.785B 18.84
Galapagos (GLPG) Belgium $5.305B 0.00
Ligand Pharmaceuticals (LGND) United States $5.220B 46.24
Ultragenyx Pharmaceutical (RARE) United States $3.821B 0.00
Immunomedics (IMMU) United States $3.631B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.545B 0.00
Horizon Pharma Public (HZNP) Ireland $3.296B 18.66
Blueprint Medicines (BPMC) United States $3.082B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.022B 0.00
China Biologic Products (CBPO) China $3.016B 19.92
Akcea Therapeutics (AKCA) United States $3.009B 0.00
Myriad Genetics (MYGN) United States $2.960B 35.42
Medicines (MDCO) United States $2.935B 0.00
Array BioPharma (ARRY) United States $2.906B 0.00
Emergent Biosolutions (EBS) United States $2.854B 22.73
Ascendis Pharma (ASND) Denmark $2.797B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.749B 0.00
Amicus Therapeutics (FOLD) United States $2.533B 0.00
Global Blood Therapeutics (GBT) United States $2.496B 0.00
Halozyme Therapeutics (HALO) United States $2.479B 33.04
Spark Therapeutics (ONCE) United States $2.259B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.239B 0.00
MyoKardia (MYOK) United States $2.234B 0.00
Acceleron Pharma (XLRN) United States $2.188B 0.00
Repligen (RGEN) United States $2.150B 72.18
REGENXBIO (RGNX) United States $2.108B 33.12
Cambrex (CBM) United States $2.044B 16.39
Momenta Pharmaceuticals (MNTA) United States $2.005B 0.00
AnaptysBio (ANAB) United States $1.986B 0.00
Reata Pharmaceuticals (RETA) United States $1.980B 0.00
Mirati Therapeutics (MRTX) United States $1.885B 0.00
G1 THERAPEUTICS (GTHX) United States $1.885B 0.00
Genomic Health (GHDX) United States $1.865B 104.02
Clovis Oncology (CLVS) United States $1.836B 0.00
Arena Pharmaceuticals (ARNA) United States $1.767B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.689B 0.00
Rubius Therapeutics (RUBY) United States $1.659B 0.00
Aimmune Therapeutics (AIMT) United States $1.638B 0.00
Atara Biotherapeutics (ATRA) United States $1.628B 0.00
Insmed (INSM) United States $1.618B 0.00
Puma Biotechnology (PBYI) United States $1.614B 0.00
Sangamo Therapeutics (SGMO) United States $1.561B 0.00
Lion Biotechnologies (IOVA) United States $1.558B 0.00
Allakos (ALLK) United States $1.530B 0.00
Denali Therapeutics (DNLI) United States $1.437B 0.00
Myovant Sciences (MYOV) United Kingdom $1.435B 0.00
Innoviva (INVA) United States $1.419B 9.11
Editas Medicine (EDIT) United States $1.386B 0.00
Solid Biosciences (SLDB) United States $1.363B 0.00
WAVE Life Sciences (WVE) Singapore $1.352B 0.00
UniQure (QURE) Netherlands $1.346B 0.00
IMMURON LTD (IMRN) Australia $1.335B 0.00
BIOHAVEN PHARM (BHVN) United States $1.329B 0.00
Acorda Therapeutics (ACOR) United States $1.327B 27.67
Alder BioPharmaceuticals (ALDR) United States $1.279B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.269B 0.00
Coherus BioSciences (CHRS) United States $1.248B 0.00
Audentes Therapeutics (BOLD) United States $1.247B 0.00
Cellectis (CLLS) France $1.171B 0.00
Intellia Therapeutics (NTLA) United States $1.166B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.142B 2180.00
Lexicon Pharmaceuticals (LXRX) United States $1.117B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.105B 0.00
Athenex (ATNX) United States $1.094B 0.00
Intra-Cellular Therapies (ITCI) United States $1.087B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.084B 0.00
Retrophin (RTRX) United States $1.072B 0.00
DBV Technologies (DBVT) France $1.045B 0.00
NeoGenomics (NEO) United States $1.023B 179.00
CytomX Therapeutics (CTMX) United States $1.018B 0.00
Apellis Pharmaceuticals (APLS) United States $0.985B 0.00
AVROBIO (AVRO) United States $0.975B 0.00
Revance Therapeutics (RVNC) United States $0.966B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.964B 0.00
Amarin (AMRN) Ireland $0.865B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.855B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.812B 0.00
Dynavax Technologies (DVAX) United States $0.798B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.796B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.771B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.769B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.769B 0.00
Aptinyx (APTX) United States $0.769B 0.00
Epizyme (EPZM) United States $0.747B 0.00
Heska (HSKA) United States $0.739B 63.60
Kura Oncology (KURA) United States $0.733B 0.00
Cara Therapeutics (CARA) United States $0.726B 0.00
Geron (GERN) United States $0.709B 0.00
InflaRx (IFRX) Germany $0.687B 0.00
UNITY Biotechnology (UBX) $0.664B 0.00
Eidos Therapeutics (EIDX) United States $0.663B 0.00
ANI Pharmaceuticals (ANIP) United States $0.662B 13.11
Viking Therapeutics (VKTX) United States $0.633B 0.00
Abeona Therapeutics (ABEO) United States $0.626B 0.00
Anika Therapeutics (ANIK) United States $0.606B 25.48
Verastem (VSTM) United States $0.590B 0.00
Sorrento Therapeutics (SRNE) United States $0.590B 0.00
AC Immune SA (ACIU) Switzerland $0.580B 0.00
Fate Therapeutics (FATE) United States $0.578B 0.00
Arcus Biosciences (RCUS) United States $0.577B 0.00
UROGEN PHARMA (URGN) Israel $0.573B 0.00
Prothena (PRTA) Ireland $0.568B 0.00
Mesoblast (MESO) Australia $0.558B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.557B 0.00
Replimune (REPL) United States $0.524B 0.00
Senesco Technologies (ELOX) United States $0.499B 0.00
Vericel (VCEL) United States $0.496B 0.00
Arbutus Biopharma (ABUS) Canada $0.490B 0.00
Novavax (NVAX) United States $0.486B 0.00
Five Prime Therapeutics (FPRX) United States $0.484B 0.00
Kindred Biosciences (KIN) United States $0.483B 0.00
ObsEva SA (OBSV) Switzerland $0.473B 0.00
Stemline Therapeutics (STML) United States $0.471B 0.00
Zymeworks (ZYME) Canada $0.447B 0.00
MiMedx (MDXG) United States $0.442B 18.95
GTx (GTXI) United States $0.438B 0.00
BeyondSpring (BYSI) United States $0.433B 0.00
Aduro Biotech (ADRO) United States $0.427B 0.00
Magenta Therapeutics (MGTA) United States $0.425B 0.00
Unum Therapeutics (UMRX) United States $0.424B 0.00
Merus (MRUS) Netherlands $0.424B 0.00
Evelo Biosciences (EVLO) United States $0.420B 0.00
Inovio Pharmaceuticals (INO) United States $0.405B 0.00
Zealand Pharma (ZEAL) Denmark $0.400B 0.00
MediciNova (MNOV) United States $0.388B 0.00
Cytokineticsorporated (CYTK) United States $0.385B 0.00
Sinovac Biotech (SVA) China $0.372B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.366B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.364B 0.00
Vital Therapies (VTL) United States $0.362B 0.00
Syros Pharmaceuticals (SYRS) United States $0.362B 0.00
Albireo Pharma (ALBO) United States $0.357B 0.00
Scholar Rock Holding (SRRK) United States $0.354B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.351B 0.00
RA PHARMCTL INC (RARX) United States $0.337B 0.00
PDL BioPharma (PDLI) United States $0.336B 4.71
Cellular Biomedicine (CBMG) United States $0.321B 0.00
Adverum Biotechnologies (ADVM) United States $0.320B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.319B 0.00
Kezar Life Sciences (KZR) United States $0.316B 0.00
Seres Therapeutics (MCRB) United States $0.315B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.312B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.312B 0.00
BioTime (BTX) United States $0.306B 0.00
Mersana Therapeutics (MRSN) United States $0.294B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.290B 0.00
Selecta Biosciences (SELB) United States $0.289B 0.00
Kala Pharmaceuticals (KALA) United States $0.288B 0.00
Celyad SA (CYAD) Belgium $0.282B 0.00
ResTORbio (TORC) United States $0.282B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.280B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.277B 0.00
Osiris Therapeutics (OSIR) United States $0.274B 0.00
Constellation Pharmaceuticals (CNST) United States $0.273B 0.00
ADMA Biologics Inc (ADMA) United States $0.272B 0.00
Athersys (ATHX) United States $0.270B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.268B 0.00
Celcuity (CELC) United States $0.263B 0.00
Kadmon Holdings (KDMN) United States $0.262B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.259B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.256B 0.00
ChromaDex (CDXC) United States $0.254B 0.00
Idera Pharmaceuticals (IDRA) United States $0.249B 0.00
Axovant Sciences (AXON) United Kingdom $0.247B 0.00
NantKwest (NK) United States $0.244B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.244B 0.00
MeiraGTx Holdings (MGTX) United States $0.240B 0.00
Cohbar (CWBR) United States $0.239B 0.00
Strongbridge Biopharma (SBBP) United States $0.236B 0.00
Allena Pharmaceuticals (ALNA) United States $0.226B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.225B 0.00
Liquidia Technologies (LQDA) United States $0.222B 0.00
Kamada (KMDA) Israel $0.221B 17.19
Clearside Biomedical (CLSD) United States $0.217B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.201B 0.00
Synlogic (SYBX) United States $0.193B 0.00
Agenus (AGEN) United States $0.191B 0.00
Spero Therapeutics (SPRO) United States $0.191B 0.00
Enzo Biochem (ENZ) United States $0.189B 0.00
Palatin Technologies (PTN) United States $0.186B 7.19
Protagonist Therapeutics (PTGX) United States $0.182B 0.00
Menlo Therapeutics (MNLO) United States $0.182B 0.00
Signal Genetics (MGEN) United States $0.179B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.174B 0.00
TOCAGEN INC (TOCA) United States $0.172B 0.00
MannKind (MNKD) United States $0.170B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.168B 0.00
Mustang Bio (MBIO) United States $0.168B 0.00
Krystal Biotech (KRYS) United States $0.167B 0.00
Compugen (CGEN) Israel $0.164B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.164B 0.00
OVID THERAPEUTC (OVID) United States $0.161B 0.00
Cue Biopharma (CUE) United States $0.159B 0.00
BioDelivery Sciences (BDSI) United States $0.156B 0.00
XBiotech (XBIT) United States $0.155B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.155B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.150B 0.00
Pfenex (PFNX) United States $0.148B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.147B 0.00
XOMA (XOMA) United States $0.142B 15.01
Pluristem Therapeutics (PSTI) Israel $0.139B 0.00
Cerecor (CERC) United States $0.137B 16.92
Intec Pharma (NTEC) Israel $0.136B 0.00
BioXcel Therapeutics (BTAI) United States $0.133B 0.00
Provention Bio (PRVB) United States $0.132B 0.00
Motif Bio Plc (MTFB) United States $0.132B 0.00
Monster Digital (INNT) United States $0.130B 0.00
Organovo Holdings (ONVO) United States $0.129B 0.00
VBI Vaccines (VBIV) United States $0.126B 0.00
Aptevo Therapeutics (APVO) United States $0.123B 0.00
Checkpoint Therapeutics (CKPT) United States $0.122B 0.00
Catalyst Biosciences (CBIO) United States $0.121B 0.00
Anavex Life Sciences (AVXL) United States $0.121B 0.00
Trevena (TRVN) United States $0.119B 0.00
Cidara Therapeutics (CDTX) United States $0.118B 0.00
Cocrystal Pharma (COCP) United States $0.117B 0.00
PSivida (EYPT) United States $0.111B 0.00
Fortress Biotech (FBIO) United States $0.110B 0.00
Tapimmune (TPIV) United States $0.106B 0.00
Leap Therapeutics (LPTX) United States $0.103B 0.00
NewLink Genetics (NLNK) United States $0.103B 0.00
Orgenesis (ORGS) United States $0.101B 0.00
Aptose Biosciences (APTO) Canada $0.098B 0.00
Eleven Biotherapeutics (SESN) United States $0.093B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.092B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.090B 0.00
ScPharmaceuticals (SCPH) United States $0.087B 0.00
Asterias Biotherapeutics (AST) United States $0.086B 0.00
Alcobra (ARCT) Israel $0.086B 0.00
Ophthotech (OPHT) United States $0.085B 0.55
Proteostasis Therapeutics (PTI) United States $0.083B 0.00
OncoSec Medical (ONCS) United States $0.083B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.077B 0.00
Histogenics (HSGX) United States $0.076B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.076B 0.00
Sophiris Bio (SPHS) United States $0.075B 0.00
Advaxis (ADXS) United States $0.075B 0.00
Applied Genetic Technologies (AGTC) United States $0.074B 0.00
Oncolytics Biotech (ONCY) Canada $0.074B 0.00
Protalix BioTherapeutics (PLX) Israel $0.071B 0.00
Celldex Therapeutics (CLDX) United States $0.069B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.068B 0.00
Evogene (EVGN) Israel $0.068B 0.00
VIVUS (VVUS) United States $0.067B 0.00
Prima BioMed (IMMP) Australia $0.067B 0.00
Alimera Sciences (ALIM) United States $0.067B 0.00
Axsome Therapeutics (AXSM) United States $0.060B 0.00
TRACON Pharmaceuticals (TCON) United States $0.060B 0.00
Novelion Therapeutics (NVLN) Canada $0.059B 0.00
Entera Bio (ENTX) Israel $0.058B 0.00
Neothetics (EVFM) United States $0.057B 0.00
Eyenovia (EYEN) United States $0.055B 0.00
VolitionRX (VNRX) Singapore $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.050B 0.00
Caladrius Biosciences (CLBS) United States $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.046B 0.00
Zosano Pharma (ZSAN) United States $0.046B 0.00
CorMedix Inc (CRMD) United States $0.046B 0.00
Celsion (CLSN) United States $0.045B 0.00
Chiasma (CHMA) United States $0.043B 0.00
Moleculin Biotech (MBRX) United States $0.043B 0.00
GENPREX INC (GNPX) United States $0.042B 0.00
AZURRX BIOPHARM (AZRX) United States $0.040B 0.00
Proteon Therapeutics (PRTO) United States $0.040B 0.00
VTv Therapeutics (VTVT) United States $0.039B 0.00
Bellerophon Therapeutics (BLPH) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
CytRx (CYTR) United States $0.036B 0.00
AquaBounty Technologies (AQB) United States $0.032B 0.00
Arsanis (ASNS) United States $0.032B 0.00
Aileron Therapeutics (ALRN) United States $0.031B 0.00
BioPharmX (BPMX) United States $0.031B 0.00
Benitec Biopharma (BNTC) Australia $0.031B 0.00
AEterna Zentaris (AEZS) United States $0.031B 62.67
OvaScience (OVAS) United States $0.029B 0.00
VistaGen Therapeutics (VTGN) United States $0.029B 0.00
Vical (VICL) United States $0.028B 0.00
Edge Therapeutics (EDGE) United States $0.028B 0.00
Oncobiologics (ONS) United States $0.028B 0.00
Adial Pharmaceuticals (ADIL) United States $0.025B 0.00
Cellect Biotechnology (APOP) Israel $0.024B 0.00
Cel-Sci (CVM) United States $0.023B 0.00
Soligenix (SNGX) United States $0.023B 0.00
Cleveland BioLabs (CBLI) United States $0.023B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
RestorGenex (DFFN) United States $0.021B 0.00
Gemphire Therapeutics (GEMP) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
AmpliPhi Biosciences (APHB) United States $0.019B 0.00
ATyr Pharma (LIFE) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.019B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Prana Biotechnology (PRAN) Australia $0.019B 0.00
Neuralstem (CUR) United States $0.017B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Hemispherx BioPharma (HEB) United States $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.013B 6.57
Cerulean Pharma (DARE) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Synthetic Biologics (SYN) United States $0.010B 0.00
Flex Pharma (FLKS) United States $0.010B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
IBio (IBIO) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
Galena Biopharma (SLS) United States $0.007B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
Oragenics (OGEN) United States $0.003B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.002B 0.00
Aytu Bioscience (AYTU) United States $0.001B 0.00